Ambient Biosciences
Ambient Biosciences is a global leader in biostabilization, dedicated to eliminating cold chain reliance and improving global health equity through innovative biomolecule stabilization technology. Their patented Capillary-Assisted Vitrification (CAV) process enables room-temperature storage and shipping of sensitive reagents and biomolecules, offering a superior alternative to traditional lyophilization and cryopreservation. With a values-driven, diverse team of scientific experts and visionary leaders, Ambient Biosciences is committed to transforming laboratory operations, reducing costs and waste, and making life sciences more accessible and sustainable worldwide.
Industries
N/A
Nr. of Employees
small (1-50)
Ambient Biosciences
1600 Huron Parkway, Bldg 520, Rm 2390, Ann Arbor, MI 48109
Patents
Products
Benchtop vitrification instrument
Compact laboratory instrument that performs capillary-mediated vitrification cycles for producing ambient-stable reagents with cycle times under two hours.
Porous scaffolds and consumables
Sheet and form-factor consumables (microporous scaffolds) for sample loading and stabilization, available in multiple formats for different sample types.
Stabilization buffer formulation (ready‑to‑use)
Ready-to-use buffer formulations intended for preparing biomolecules prior to application to scaffolds and vitrification, designed to preserve activity after ambient storage.
Ambient-stable reagent kits (research use)
Pre-stabilized reagent kits provided on porous scaffold formats for RUO evaluation (examples include dried conjugates and enzyme reagents delivered as single-use units).
Benchtop vitrification instrument
Compact laboratory instrument that performs capillary-mediated vitrification cycles for producing ambient-stable reagents with cycle times under two hours.
Porous scaffolds and consumables
Sheet and form-factor consumables (microporous scaffolds) for sample loading and stabilization, available in multiple formats for different sample types.
Stabilization buffer formulation (ready‑to‑use)
Ready-to-use buffer formulations intended for preparing biomolecules prior to application to scaffolds and vitrification, designed to preserve activity after ambient storage.
Ambient-stable reagent kits (research use)
Pre-stabilized reagent kits provided on porous scaffold formats for RUO evaluation (examples include dried conjugates and enzyme reagents delivered as single-use units).
Expertise Areas
- Biomolecule stabilization
- Alternatives to lyophilization
- Assay reagent formulation and single-use formats
- Thermal stability testing and functional validation
Key Technologies
- Capillary-mediated vitrification
- Porous scaffold drying and deposition
- Vacuum-assisted rapid desiccation
- Stabilization buffer formulation
Key People
Founder and Chief Innovation Officer
Founder and Chief Innovation Officer
News & Updates
Ambient Biosciences holds patents for their Capillary-Assisted Vitrification (CAV) process, ensuring biomolecules retain activity after years of room temperature storage and enabling extended shelf life.
Ambient Biosciences has successfully partnered with organizations such as B2S Life Sciences, Vanderbilt University, AssayQuant Technologies, and Ambry Genetics to validate and apply their stabilization technology in real-world settings.
Study exploring CAV as an alternative to lyophilization for vaccine stabilization, showing comparable immunogenicity and quality, and confirming broad compatibility and thermostability benefits.
Case study with B2S Life Sciences demonstrating successful stabilization of antibodies for ambient storage, preserving molecular integrity and functionality.
Press release announcing the Early Access Program for partners to trial CAV technology, reducing cold storage reliance and extending shelf life.
Research report supporting CMV as a viable alternative to frozen reagent storage, with significant impact on reagent stability, assay performance, and sustainability.
Ambient Biosciences holds patents for their Capillary-Assisted Vitrification (CAV) process, ensuring biomolecules retain activity after years of room temperature storage and enabling extended shelf life.
Ambient Biosciences has successfully partnered with organizations such as B2S Life Sciences, Vanderbilt University, AssayQuant Technologies, and Ambry Genetics to validate and apply their stabilization technology in real-world settings.
Study exploring CAV as an alternative to lyophilization for vaccine stabilization, showing comparable immunogenicity and quality, and confirming broad compatibility and thermostability benefits.
Case study with B2S Life Sciences demonstrating successful stabilization of antibodies for ambient storage, preserving molecular integrity and functionality.
Press release announcing the Early Access Program for partners to trial CAV technology, reducing cold storage reliance and extending shelf life.
Research report supporting CMV as a viable alternative to frozen reagent storage, with significant impact on reagent stability, assay performance, and sustainability.